Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.
Kong G, Wunderlich M, Yang D, Ranheim EA, Young KH, Wang J, Chang YI, Du J, Liu Y, Tey SR, Zhang X, Juckett M, Mattison R, Damnernsawad A, Zhang J, Mulloy JC, Zhang J.
Kong G, et al.
J Clin Invest. 2014 Jun;124(6):2762-73. doi: 10.1172/JCI74182. Epub 2014 May 8.
J Clin Invest. 2014.
PMID: 24812670
Free PMC article.